目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 20)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 SMART PILLS INDUSTRY: MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 24)
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.1.3 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 SMART PILLS MARKET: SEGMENTAL EXTRAPOLATION
FIGURE 7 SMART PILLS INDUSTRY: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023-2028)
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION METHODOLOGY
FIGURE 9 MARKET: DATA TRIANGULATION METHODOLOGY
2.3 MARKET SHARE ANALYSIS
2.4 STUDY ASSUMPTIONS
2.5 LIMITATIONS
2.5.1 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
TABLE 1 SMART PILLS INDUSTRY: RISK ASSESSMENT ANALYSIS
2.7 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 36)
FIGURE 10 SMART PILLS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 11 SMART PILLS INDUSTRY, BY TARGET AREA, 2023 VS. 2028 (USD MILLION)
FIGURE 12 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF MARKET

4 PREMIUM INSIGHTS (Page No. - 39)
4.1 SMART PILLS MARKET OVERVIEW
FIGURE 14 RISING TECHNOLOGICAL ADVANCEMENTS IN CAPSULE ENDOSCOPES TO DRIVE MARKET
4.2 NORTH AMERICA: SMART PILLS INDUSTRY, BY END USER AND COUNTRY
FIGURE 15 HOSPITALS ACCOUNTED FOR LARGEST MARKET SHARE IN US FOR 2022
4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.4 MARKET: REGIONAL MIX
FIGURE 17 NORTH AMERICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.5 MARKET: DEVELOPING VS. EMERGING MARKETS
FIGURE 18 EMERGING MARKETS TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 42)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 SMART PILLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 2 MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Rising demand for noninvasive diagnostic monitoring devices
5.2.1.2 Technological advancements in capsule endoscopy
5.2.1.3 Increasing incidence of colon cancer
5.2.2 RESTRAINTS
5.2.2.1 High costs
5.2.2.2 Technical limitations associated with accuracy of smart pills
5.2.3 OPPORTUNITIES
5.2.3.1 Growing demand for advanced drug delivery systems
5.2.3.2 Rising need for rapid drug delivery development
5.2.4 CHALLENGES
5.2.4.1 Patient privacy concerns
5.3 INDUSTRY TRENDS
5.3.1 ADVANCEMENTS IN SENSOR TECHNOLOGY
5.3.2 INTEGRATION WITH WEARABLE DEVICES
5.4 TECHNOLOGY ANALYSIS
5.4.1 SELF-POWERED INGESTIBLE SMART PILL
5.4.2 ADAPTIVE FRAME RATE TECHNOLOGY
5.4.3 IMAG (INGESTIBLE MICRODEVICES FOR ANATOMIC MAPPING OF GASTROINTESTINAL TRACT)
TABLE 3 SENSOR AND BATTERY TYPES USED FOR CAPSULE ENDOSCOPY PRODUCTS
TABLE 4 SENSOR USED FOR VITAL SIGN MONITORING AND DRUG INGESTION TRACKING PRODUCTS
TABLE 5 MARKET: DRUGS UNDER PIPELINE
5.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 PORTER’S FIVE FORCES ANALYSIS
5.5.1 THREAT OF NEW ENTRANTS
5.5.2 THREAT OF SUBSTITUTES
5.5.3 BARGAINING POWER OF SUPPLIERS
5.5.4 BARGAINING POWER OF BUYERS
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 ECOSYSTEM ANALYSIS
FIGURE 20 MARKET: ECOSYSTEM ANALYSIS
5.7 VALUE CHAIN ANALYSIS
FIGURE 21 MARKET: VALUE CHAIN ANALYSIS
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR SMART PILLS
FIGURE 22 PATENT PUBLICATION TRENDS (JANUARY 2012-DECEMBER 2022)
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 23 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR SMART PILLS PATENTS (JANUARY 2012-DECEMBER 2022)
FIGURE 24 TOP APPLICANTS FOR SMART PILLS PATENTS (COUNTRY/REGION) (JANUARY 2012-JANUARY 2022)
TABLE 7 MARKET: LIST OF PATENTS (2020-2023)
5.9 PRICING ANALYSIS
TABLE 8 PRICE RANGE FOR SMART PILLS (2022)
5.10 KEY CONFERENCES AND EVENTS
TABLE 9 SMART PILLS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023-2024)
5.11 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 REGULATORY ANALYSIS
5.12.1 NORTH AMERICA
5.12.1.1 US
TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.12.2 EUROPE
5.12.3 ASIA PACIFIC
5.12.3.1 Japan
TABLE 13 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.12.3.2 China
TABLE 14 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION (%)
5.13.2 BUYING CRITERIA
FIGURE 26 KEY BUYING CRITERIA FOR SMART PILLS, BY APPLICATION
TABLE 16 KEY BUYING CRITERIA FOR SMART PILLS, BY APPLICATION

6 SMART PILLS MARKET, BY TARGET AREA (Page No. - 67)
6.1 INTRODUCTION
TABLE 17 MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
6.2 SMALL INTESTINE
6.2.1 RISING INCIDENCE OF SMALL INTESTINE DISORDERS TO DRIVE MARKET
TABLE 18 MARKET FOR SMALL INTESTINE, BY COUNTRY, 2021-2028 (USD MILLION)
6.3 LARGE INTESTINE
6.3.1 INCREASING INCIDENCE OF COLORECTAL CANCER TO SUPPORT MARKET GROWTH
TABLE 19 MARKET FOR LARGE INTESTINE, BY COUNTRY, 2021-2028 (USD MILLION)
6.4 ESOPHAGUS
6.4.1 EVALUATION AND MONITORING OF BARRETT’S ESOPHAGUS TO PROPEL MARKET
TABLE 20 MARKET FOR ESOPHAGUS, BY COUNTRY, 2021-2028 (USD MILLION)
6.5 STOMACH
6.5.1 IMPROVED DIAGNOSTIC ACCURACY TO SUPPORT MARKET GROWTH
TABLE 21 MARKET FOR STOMACH, BY COUNTRY, 2021-2028 (USD MILLION)

7 SMART PILLS MARKET, BY APPLICATION (Page No. - 74)
7.1 INTRODUCTION
TABLE 22 MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
7.2 CAPSULE ENDOSCOPY
7.2.1 ABILITY TO ASSESS GASTROINTESTINAL BLEEDING AND SMALL-BOWL TUMORS TO DRIVE MARKET
TABLE 23 CAPSULE ENDOSCOPES OFFERED BY KEY MARKET PLAYERS
TABLE 24 MARKET FOR CAPSULE ENDOSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
7.3 VITAL SIGN MONITORING
7.3.1 LAUNCH OF INNOVATIVE SENSOR TECHNOLOGIES TO PROPEL MARKET
TABLE 25 VITAL SIGN MONITORING SMART PILLS UNDER PIPELINE
TABLE 26 MARKET FOR VITAL SIGN MONITORING, BY COUNTRY, 2021-2028 (USD MILLION)
7.4 TARGETED DRUG DELIVERY
7.4.1 SITE-SPECIFIC DRUG DELIVERY INTEGRATION WITH SMART PILLS TO SUPPORT MARKET GROWTH
TABLE 27 TARGETED DRUG DELIVERY SMART PILLS UNDER PIPELINE
TABLE 28 MARKET FOR TARGETED DRUG DELIVERY, BY COUNTRY, 2021-2028 (USD MILLION)

8 SMART PILLS MARKET, BY END USER (Page No. - 81)
8.1 INTRODUCTION
TABLE 29 MARKET BY END USER, 2021-2028 (USD MILLION)
8.2 HOSPITALS
8.2.1 RISING NEED FOR TECHNOLOGICALLY ADVANCED ENDOSCOPY PROCEDURES TO DRIVE MARKET
TABLE 30 MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
8.3 DIAGNOSTIC CENTERS
8.3.1 GROWING PREFERENCE FOR NONINVASIVE DIAGNOSTICS TO PROPEL MARKET
TABLE 31 MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
8.4 OTHER END USERS
TABLE 32 MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

9 SMART PILLS MARKET, BY REGION (Page No. - 86)
9.1 INTRODUCTION
TABLE 33 SMART PILLS INDUSTRY, BY REGION, 2021-2028 (USD MILLION)
TABLE 34 CAPSULE ENDOSCOPY MARKET, BY REGION, 2021-2028 (MILLION UNITS)
TABLE 35 VITAL SIGN MONITORING MARKET, BY REGION, 2021-2028 (MILLION UNITS)
9.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: SMART PILLS MARKET SNAPSHOT
TABLE 36 NORTH AMERICA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 37 NORTH AMERICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 38 NORTH AMERICA: MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
TABLE 39 NORTH AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.2.1 US
9.2.1.1 Favorable reimbursements for endoscopy procedures to drive market
TABLE 40 US: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 41 US: MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
TABLE 42 US: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising incidence of IBD to drive market
TABLE 43 CANADA: SMART PILLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 44 CANADA: MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
TABLE 45 CANADA: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.2.3 NORTH AMERICA: RECESSION IMPACT
9.3 EUROPE
TABLE 46 EUROPE: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 47 EUROPE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 48 EUROPE: MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
TABLE 49 EUROPE: SMART PILLS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Rising incidence of Chron’s disease to drive market
TABLE 50 GERMANY: SMART PILLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 51 GERMANY: MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
TABLE 52 GERMANY: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.3.2 UK
9.3.2.1 Utilization of capsule endoscopy for bowel cancer to drive market
TABLE 53 UK: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 54 UK: MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
TABLE 55 UK: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Reimbursement coverage for small bowel capsule endoscopy to drive market
TABLE 56 FRANCE: SMART PILLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 57 FRANCE: MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
TABLE 58 FRANCE: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Rising adoption of technologically advanced endoscopes to support market growth
TABLE 59 ITALY: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 60 ITALY: MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
TABLE 61 ITALY: SMART PILLS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
9.3.5 REST OF EUROPE
TABLE 62 REST OF EUROPE: SMART PILLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 63 REST OF EUROPE: MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
TABLE 64 REST OF EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.3.6 EUROPE: RECESSION IMPACT
9.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 65 ASIA PACIFIC: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 66 ASIA PACIFIC: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
TABLE 68 ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Rising incidence of gastric cancer to drive market
TABLE 69 JAPAN: SMART PILLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 70 JAPAN: MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
TABLE 71 JAPAN: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Increasing funding initiatives for development of smart pills to fuel market
TABLE 72 CHINA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 73 CHINA: MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
TABLE 74 CHINA: SMART PILLS INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Rising incidence of IBD to support market growth
TABLE 75 INDIA: SMART PILLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 76 INDIA: MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
TABLE 77 INDIA: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 78 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 79 REST OF ASIA PACIFIC: MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
TABLE 80 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.4.5 ASIA PACIFIC: RECESSION IMPACT
9.5 REST OF THE WORLD
TABLE 81 REST OF THE WORLD: SMART PILLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 82 REST OF THE WORLD: MARKET, BY TARGET AREA, 2021-2028 (USD MILLION)
TABLE 83 REST OF THE WORLD: MARKET, BY END USER, 2021-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 114)
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 84 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
10.2.1 REVENUE SHARE ANALYSIS
FIGURE 29 REVENUE SHARE ANALYSIS OF LEADING PLAYERS
10.2.2 MARKET SHARE ANALYSIS
FIGURE 30 SMART PILLS MARKET SHARE, BY KEY PLAYER (2022)
10.3 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS
10.3.1 STARS
10.3.2 EMERGING LEADERS
10.3.3 PERVASIVE PLAYERS
10.3.4 PARTICIPANTS
FIGURE 31 SMART PILLS INDUSTRY: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
10.4 COMPANY FOOTPRINT ANALYSIS
TABLE 85 MARKET: COMPANY FOOTPRINT ANALYSIS
10.4.1 APPLICATION FOOTPRINT ANALYSIS
TABLE 86 MARKET: APPLICATION FOOTPRINT
10.4.2 TARGET AREA FOOTPRINT ANALYSIS
TABLE 87 MARKET: TARGET AREA FOOTPRINT
10.4.3 END USER FOOTPRINT ANALYSIS
TABLE 88 MARKET: END USER FOOTPRINT
10.4.4 REGIONAL FOOTPRINT ANALYSIS
TABLE 89 MARKET: REGIONAL FOOTPRINT
10.5 COMPETITIVE SCENARIO
10.5.1 PRODUCT LAUNCHES & APPROVALS
TABLE 90 MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-JUNE 2023)
10.5.2 DEALS
TABLE 91 SMART PILLS INDUSTRY: DEALS (JANUARY 2020-JUNE 2023)
10.5.3 OTHER DEVELOPMENTS
TABLE 92 MARKET: OTHER DEVELOPMENTS (JANUARY 2020-JUNE 2023)

11 COMPANY PROFILES (Page No. - 128)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY PLAYERS
11.1.1 OLYMPUS CORPORATION
TABLE 93 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 32 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
11.1.2 CAPSOVISION, INC.
TABLE 94 CAPSOVISION, INC.: BUSINESS OVERVIEW
11.1.3 MEDTRONIC PLC
TABLE 95 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 33 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
11.1.4 INTROMEDIC
TABLE 96 INTROMEDIC: BUSINESS OVERVIEW
11.1.5 ANX ROBOTICA CORP.
TABLE 97 ANX ROBOTICA CORP.: BUSINESS OVERVIEW
11.1.6 SHENZHEN JIFU MEDICAL TECHNOLOGY CO., LTD.
TABLE 98 SHENZHEN JIFU MEDICAL TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
11.1.7 CHONGQING JINSHAN SCIENCE & TECHNOLOGY (GROUP) CO., LTD.
TABLE 99 CHONGQING JINSHAN SCIENCE & TECHNOLOGY (GROUP) CO., LTD.: BUSINESS OVERVIEW
11.1.8 RF CO., LTD.
TABLE 100 RF CO., LTD.: BUSINESS OVERVIEW
11.1.9 ETECTRX
TABLE 101 ETECTRX: BUSINESS OVERVIEW
11.1.10 BODYCAP
TABLE 102 BODYCAP: BUSINESS OVERVIEW
11.1.11 OTSUKA AMERICA PHARMACEUTICAL, INC.
TABLE 103 OTSUKA AMERICA PHARMACEUTICAL, INC.: BUSINESS OVERVIEW
11.1.12 CHECK-CAP LTD.
TABLE 104 CHECK-CAP LTD.: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 147)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS